Resource for professionals in the bioresearch industry- information on biopharm contract manufacturing, biopharm processing, bioresearch technology, biopharm manufacturing, mixing.
Company name: light sciences oncology inc: company address: se douglas st ste snoqualmie, wa: company phone: (425) -2800: company website:. Light sciences oncology elects former missioner frank young, md, phd, to board of directors.
Company: light sciences oncologybased: bellevue, waamount: $41m investors: novo, essex woodlands health ventures, undisclosed firm, undisclosed firm, adams street partners. Litx consists of a light-activated drug, talaporfin sodium (ls11, light sciences oncology, snoqualmie, washington), and a light generating device, composed of light-emitting.
Represented light sciences oncology, inc in its acquisition of assets of life sciences, llc.
Get light sciences oncology, pany research & investing information find executive management and the pany developments. News about tech, money and innovation life sciences briefing: monday, feb, today s headlines: polyremedy, developer of robotic wound care, takes in $25m (release).
Light sciences oncology expands development of novel targeted drug aptocine(tm) for prostate conditions with start-up of phase bph trial. Llew keltner flies about, miles a year the ceo of light sciences oncology insists he can t imagine doing his job any other way there are doctors in. Free online library: light sciences pletes $ million financing for late stage development of litx(tm); announces spin-off from light sciences corporation and.
Press room press releases; contact us; clinical trials phase hepatocellular carcinoma (hcc) phase metastatic colorectal cancer (mcrc) phase benign prostatic.
Natural sciences, immunology and oncology in medicine, in addition to intercultural and media studies in the hum ties and social sciences for nuclear physics or the light water. Light sciences oncology initiates phase ii trial of litx therapy in patients with glioma first patient enrolled in study to evaluate the safety of light infusion therapy.
Light sciences oncology receives special protocol assessment for pivotal phase iii trial of litx therapy in metastatic colorectal cancer light sciences oncology has announced. Light sciences oncology inc withdrew its ipo filing friday, citing unfavorable market conditions it originally filed ipo paperwork in april,. Light sciences oncology initiates phase ii trial of litx therapy in patients with glioma from business wire provided by find articles at bnet.
Light sciences oncology, inc (lso) announced pletion of enrollment in a global phase clinical trial of light infusion therapy(tm) (litx(tm)) as a treatment for. Light sciences oncology, a bellevue, wa-based developer of cancer drugs, said it pleted enrollment of patients with liver tumors in a clinical trial.
Light sciences oncology receives special protocol assessment for pivotal phase iii trial of litx therapy in metastatic colorectal cancer second spa agreement advances the. Light sciences oncology, inc (lso) today announced the treatment of the first patients in a phase clinical trial of its innovative targeted drug treatment aptocine(tm. Representation of light sciences oncology, inc in its venture capital financings and general corporate matters. Sponsored by: light sciences oncology: information provided by: light sciences oncology: clinicaltrialsgov identifier: nct00918034.
Free online library: light sciences oncology initiates phase ii trial of litx(tm) therapy in patients with glioma by "business wire"; business, international brain tumors care. Tradingmarkets news for lson - light sciences pletes enrollment in phase iii liver cancer trial.
Company overview light sciences oncology (lso) is developing aptocine for solid tumors as well as other indications aptocine (talaporfin sodium) is a water-soluble drug.
Cancer research firm light sciences oncology inc revealed monday that it has appointed david p holveck to its board of directors holveck, who es the boar s eighth member.
Light sciences oncology, inc (lso) announced the treatment of the first patients in a phase clinical trial of its innovative targeted drug treatment aptocine(tm) (talaporfin. High technology news and information for the pacific northwest region. Ergomed appointed preferred provider to light sciences oncology (lso) ergomed and lso ed pr jan09..
Light Sciences Oncology |